Review Article
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Neural Basis for Regulation of Vasopressin Secretion by Presystemic Anticipated Disturbances in Osmolality, and by Hypoglycemia
Neural Basis for Regulation of Vasopressin Secretion by Presystemic Anticipated Disturbances in Osmolality, and by Hypoglycemia The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Kim, Angela. 2020. Neural Basis for Regulation of Vasopressin Secretion by Presystemic Anticipated Disturbances in Osmolality, and by Hypoglycemia. Doctoral dissertation, Harvard University, Graduate School of Arts & Sciences. Citable link https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37365939 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Neural Basis for Regulation of Vasopressin Secretion by Presystemic Anticipated Disturbances in Osmolality, and by Hypoglycemia A dissertation presented by Angela Kim to The Division of Medical Sciences in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Neuroscience Harvard University Cambridge, Massachusetts April 2020 © 2020 Angela Kim All rights reserved. Dissertation Advisor: Bradford B. Lowell Angela Kim Neural Basis for Regulation of Vasopressin Secretion by Presystemic Anticipated Disturbances in Osmolality, and by Hypoglycemia Abstract Vasopressin (AVP), released by magnocellular AVP neurons of the hypothalamus, is a multifaceted hormone. AVP regulates many physiological processes including blood osmolality, blood glucose, and blood pressure. In this dissertation, I present two independent studies investigating the neural mechanism for role of AVP in fluid and glucose homeostasis. In regards to regulating water excretion and hence blood osmolality, magnocellular AVP neurons are regulated by two temporally distinct signals: 1) slow systemic signals that convey systemic osmolality information, and 2) rapid ‘presystemic’ signals that anticipate future osmotic challenges. -
Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia
Article Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia Jason C. George ,1 Waleed Zafar,2 Ion Dan Bucaloiu,1 and Alex R. Chang 1,2 Abstract Background and objectives Rapid correction of severe hyponatremia can result in serious neurologic complications, including osmotic demyelination. Few data exist on incidence and risk factors of rapid 1Department of correction or osmotic demyelination. Nephrology, Geisinger Medical Center, Design, setting, participants, & measurements In a retrospective cohort of 1490 patients admitted with serum Danville, , Pennsylvania; and sodium 120 mEq/L to seven hospitals in the Geisinger Health System from 2001 to 2017, we examined the 2 incidence and risk factors of rapid correction and osmotic demyelination. Rapid correction was defined as serum Kidney Health . Research Institute, sodium increase of 8 mEq/L at 24 hours. Osmotic demyelination was determined by manual chart review of Geisinger, Danville, all available brain magnetic resonance imaging reports. Pennsylvania Results Mean age was 66 years old (SD=15), 55% were women, and 67% had prior hyponatremia (last outpatient Correspondence: sodium ,135 mEq/L). Median change in serum sodium at 24 hours was 6.8 mEq/L (interquartile range, 3.4–10.2), Dr. Alexander R. Chang, and 606 patients (41%) had rapid correction at 24 hours. Younger age, being a woman, schizophrenia, lower Geisinger Medical , Center, 100 North Charlson comorbidity index, lower presentation serum sodium, and urine sodium 30 mEq/L were associated Academy Avenue, with greater risk of rapid correction. Prior hyponatremia, outpatient aldosterone antagonist use, and treatment at an Danville, PA 17822. academic center were associated with lower risk of rapid correction. -
Electrolyte and Acid-Base
Special Feature American Society of Nephrology Quiz and Questionnaire 2013: Electrolyte and Acid-Base Biff F. Palmer,* Mark A. Perazella,† and Michael J. Choi‡ Abstract The Nephrology Quiz and Questionnaire (NQ&Q) remains an extremely popular session for attendees of the annual meeting of the American Society of Nephrology. As in past years, the conference hall was overflowing with interested audience members. Topics covered by expert discussants included electrolyte and acid-base disorders, *Department of Internal Medicine, glomerular disease, ESRD/dialysis, and transplantation. Complex cases representing each of these categories University of Texas along with single-best-answer questions were prepared by a panel of experts. Prior to the meeting, program Southwestern Medical directors of United States nephrology training programs answered questions through an Internet-based ques- Center, Dallas, Texas; † tionnaire. A new addition to the NQ&Q was participation in the questionnaire by nephrology fellows. To review Department of Internal Medicine, the process, members of the audience test their knowledge and judgment on a series of case-oriented questions Yale University School prepared and discussed by experts. Their answers are compared in real time using audience response devices with of Medicine, New the answers of nephrology fellows and training program directors. The correct and incorrect answers are then Haven, Connecticut; ‡ briefly discussed after the audience responses, and the results of the questionnaire are displayed. This article and Division of recapitulates the session and reproduces its educational value for the readers of CJASN. Enjoy the clinical cases Nephrology, Department of and expert discussions. Medicine, Johns Clin J Am Soc Nephrol 9: 1132–1137, 2014. -
Therapeutic Potential of Vasopressin-Receptor Antagonists in Heart Failure
J Pharmacol Sci 124, 1 – 6 (2014) Journal of Pharmacological Sciences © The Japanese Pharmacological Society Current Perspective Therapeutic Potential of Vasopressin-Receptor Antagonists in Heart Failure Yasukatsu Izumi1,*, Katsuyuki Miura2, and Hiroshi Iwao1 1Department of Pharmacology, 2Applied Pharmacology and Therapeutics, Osaka City University Medical School, Osaka 545-8585, Japan Received October 2, 2013; Accepted November 17, 2013 Abstract. Arginine vasopressin (AVP) is a 9-amino acid peptide that is secreted from the posterior pituitary in response to high plasma osmolality and hypotension. AVP has important roles in circulatory and water homoeostasis, which are mediated by oxytocin receptors and by AVP receptor subtypes: V1a (mainly vascular), V1b (pituitary), and V2 (renal). Vaptans are orally and intravenously active nonpeptide vasopressin-receptor antagonists. Recently, subtype-selective nonpeptide vasopressin-receptor agonists have been developed. A selective V1a-receptor antago- nist, relcovaptan, has shown initial positive results in the treatment of Raynaud’s disease, dysmen- orrhea, and tocolysis. A selective V1b-receptor antagonist, nelivaptan, has beneficial effects in the treatment of psychiatric disorders. Selective V2-receptor antagonists including mozavaptan, lixivaptan, satavaptan, and tolvaptan induce highly hypotonic diuresis without substantially affecting the excretion of electrolytes. A nonselective V1a/V2-receptor antagonist, conivaptan, is used in the treatment for euvolaemic or hypervolemic hyponatremia. Recent basic and clinical studies have shown that AVP-receptor antagonists, especially V2-receptor antagonists, may have therapeutic potential for heart failure. This review presents current information about AVP and its antagonists. Keywords: arginine vasopressin, diuretic, heart failure, vasopressin receptor antagonist 1. Introduction receptor blockers, diuretics, b-adrenoceptor blockers, digitalis glycosides, and inotropic agents (4). -
A 27-Month-Old Boy with Polyuria and Polydipsia
UC Davis UC Davis Previously Published Works Title A 27-Month-Old Boy with Polyuria and Polydipsia. Permalink https://escholarship.org/uc/item/8x24x4p2 Authors Lee, Yvonne Winnicki, Erica Butani, Lavjay et al. Publication Date 2018 DOI 10.1155/2018/4281217 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Hindawi Case Reports in Pediatrics Volume 2018, Article ID 4281217, 4 pages https://doi.org/10.1155/2018/4281217 Case Report A 27-Month-Old Boy with Polyuria and Polydipsia Yvonne Lee,1 Erica Winnicki,2 Lavjay Butani ,3 and Stephanie Nguyen 3 1Department of Pediatrics, Section of Endocrinology, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA 2Department of Pediatrics, Section of Nephrology, University of California, San Francisco, San Francisco, CA, USA 3Department of Pediatrics, Section of Nephrology, University of California, Davis, Sacramento, CA, USA Correspondence should be addressed to Stephanie Nguyen; [email protected] Received 16 May 2018; Accepted 1 August 2018; Published 23 August 2018 Academic Editor: Anselm Chi-wai Lee Copyright © 2018 Yvonne Lee et al. )is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Psychogenic polydipsia is a well-described phenomenon in those with a diagnosed psychiatric disorder such as schizophrenia and anxiety disorders. Primary polydipsia is differentiated from psychogenic polydipsia by the lack of a clear psychotic disturbance. We present a case of a 27-month-old boy who presented with polyuria and polydipsia. Laboratory studies, imaging, and an observed water deprivation test were consistent with primary polydipsia. -
Vaptans: a New Option in the Management of Hyponatremia
[Downloaded free from http://www.ijabmr.org on Monday, August 18, 2014, IP: 218.241.189.21] || Click here to download free Android application for this journal Educational Forum Vaptans: A new option in the management of hyponatremia Suruchi Aditya, Aditya Rattan1 Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Chandigarh. 1Consultant Cardiologist, Heartline, Panchkula, Haryana, India Abstract Arginine vasopressin (AVP) plays an important role in water and sodium homeostasis. It acts via three receptor subtypes— V1a, V 1b, and V2—distributed widely throughout the body. Vaptans are nonpeptide vasopressin receptor antagonists (VRA). By property of aquaresis, VRAs offer a novel therapy of water retention. Conivaptan is a V1a/V2 nonselective VRA approved for euvolemic and hypervolemic hyponatremia. Tolvaptan is the first oral VRA. Other potential uses of this new class of drugs include congestive heart failure (CHF), cirrhosis of liver, syndrome of inappropriate secretion of antidiuretic hormone, polycystic kidney disease, and so on. These novel drugs score over diuretics as they are not associated with electrolyte abnormalities. Though much remains to be elucidated before the VRAs are applied clinically, the future holds much promise. Key words: Aquaresis, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, vaptan, vasopressin receptor antagonists Introduction hormone (ADH), renin angiotensin aldosterone system (RAAS), sympathetic nervous system (SNS), and thirst help Hyponatremia, one of the most common electrolyte to control water homeostasis in the body and keep plasma abnormalities in hospitalized patients, is defined as serum osmolality between 275 and 290 mOsm/kg water. sodium concentration <135 mEq/L. Its prevalence is one in five of all hospitalized patients.[1] Recent clinical data suggests Hyponatremia can be associated with low, normal, or high that hyponatremia is not only a marker of disease severity but tonicity. -
Information Sheet
007 INFORMATION SHEET Pica (Eating Inedible Objects) and Polydipsia (Drinking Excessively) Introduction The following information sheet aims to All our information sheets are available to explain what causes pica and polydipsia, download free of charge. then offers some possible strategies to To enable us to continue our work please reduce these behaviours. support us or donate £3 by texting CBF to 70450. This sheet will focus on pica first, before exploring polydipsia (on page 7). Is this resource helpful? Please spend a few minutes giving us some feedback: www.surveymonkey.co.uk/r/cbfresources What is pica? Pica refers to eating objects that are inedible such as stones, coins, shampoo, clothing and cigarette butts. Children and adults may eat one specific inedible object, or lots of different ones. Research into the causes, assessment and strategies for pica is very limited. This information sheet is based on the available research and current clinical practice. What are the risks? Whilst some objects pass through the body without harm, pica can potentially be life threatening. Risks include vomiting, constipation, infections, blockages in the gut and intestines, choking and poisoning. Sometimes surgery is needed to remove objects from the gut or to repair damaged tissue. If you are worried about a child or adult who has eaten an inedible object it is vital that you contact their GP or your nearest accident and emergency department for medical advice. What causes pica? The specific causes of pica are not clear, but some conditions can increase the chance that a child or adult will develop pica. -
New Approaches of the Hyponatremia Treatment in the Elderly – an Update
FARMACIA, 2020, Vol. 68, 3 https://doi.org/10.31925/farmacia.2020.3.5 REVIEW NEW APPROACHES OF THE HYPONATREMIA TREATMENT IN THE ELDERLY – AN UPDATE ALICE BĂLĂCEANU 1,2#, SECIL OMER 1,2, SILVIU ADRIAN MARINESCU 1,3*, SILVIU MIREL PIȚURU 1#, ȘERBAN DUMITRACHE 2#, DANIELA ELENA POPA 1, ANDREEA ANTONIA GHEORGHE 2, SIRAMONA POPESCU 3, CĂTĂLIN BEJINARIU 3, OCTAV GINGHINĂ 1,2, CARMEN GIUGLEA 1,2 1“Carol Davila” University of Medicine and Pharmacy, 37 Dionisie Lupu Street, 020021, Bucharest, Romania 2“Sf. Ioan” Clinical Emergency Hospital, 13 Vitan-Bârzești Road, 042122, Bucharest, Romania 3“Bagdasar Arseni” Clinical Emergency Hospital, 12 Berceni Road, 041915, Bucharest, Romania *corresponding author: [email protected] #Authors with equal contribution. Manuscript received: December 2019 Abstract Hyponatremia (hNa) is a frequently common imbalance in the elderly hospitalized patients. It is often correlated with elevated plasma quantities of arginine vasopressin (AVP, the antidiuretic hormone) and namely it depicts a water surplus in order to prevail sodium levels. It can conduct, in a comprehensive range, to detrimental changes that can affect the entire health status, especially the central nervous system, thus increasing the mortality and morbidity of hospitalized patients in care units. The inherent treatment of hNa, mainly of the chronic form, requires the correction of serum sodium concentrations at the appropriate rate, because, augmenting it at a warp speed, it can determine permanent or fatal neurologic sequelae. In this regard, the therapy for hNa may be enlightened by egressing therapies that include vasopressin V2 and V1a receptors antagonists, with the principal role of encouraging aquaresis and rise the serum sodium levels, alongside with the electrolyte- sparing discharge of free water. -
Diabetes Insipidus View Online At
Diabetes Insipidus View online at http://pier.acponline.org/physicians/diseases/d145/d145.html Module Updated: 2013-01-29 CME Expiration: 2016-01-29 Author Robert J. Ferry, Jr., MD Table of Contents 1. Diagnosis ..........................................................................................................................2 2. Consultation ......................................................................................................................8 3. Hospitalization ...................................................................................................................10 4. Therapy ............................................................................................................................11 5. Patient Counseling ..............................................................................................................16 6. Follow-up ..........................................................................................................................17 References ............................................................................................................................19 Glossary................................................................................................................................22 Tables ...................................................................................................................................23 Figures .................................................................................................................................39 -
Hypercalcemia and Hyponatremia
Hypercalcemia and Hyponatremia Santosh Reddy MD FACP Assistant Professor Scott & White/Texas A&M Etiology of Hypercalcemia Hypercalcemia results when the entry of calcium into the circulation exceeds the excretion of calcium into the urine or deposition in bone. Sources of calcium are most commonly the bone or the gastrointestinal tract Etiology Hypercalcemia is a relatively common clinical problem. Elevation in the physiologically important ionized (or free) calcium concentration. However, 40 to 45 percent of the calcium in serum is bound to protein, principally albumin; , increased protein binding causes elevation in the serum total calcium. Increased bone resorption Primary and secondary hyperparathyroidism Malignancy Hyperthyroidism Other - Paget's disease, estrogens or antiestrogens in metastatic breast cancer, hypervitaminosis A, retinoic acid Increased intestinal calcium absorption Increased calcium intake Renal failure (often with vitamin D supplementation) Milk-alkali syndrome Hypervitaminosis D Enhanced intake of vitamin D or metabolites Chronic granulomatous diseases (eg, sarcoidosis) Malignant lymphoma Acromegaly Pseudocalcemia Hyperalbuminemia 1) severe dehydration 2) multiple myeloma who have a calcium- binding paraprotein. This phenomenon is called pseudohypercalcemia (or factitious hypercalcemia) Other causes Familial hypocalciuric hypercalcemia Chronic lithium intake Thiazide diuretics Pheochromocytoma Adrenal insufficiency Rhabdomyolysis and acute renal failure Theophylline toxicity Immobilization -
Pathophysiology of Water Electrolyte Metabolism
PATHOPHYSIOLOGY OF WATER ELECTROLYTE METABOLISM. PATHOPHYSIOLOGY OF MINERAL METABOLISM. I. PLAN OF STUDY OF THE TOPIC. 1. Changes in water distribution and water volume. 2. Types of dehydration, causes and mechanisms of development. 3. Effect of dehydration on the body. 4. Edema and dropsy: definition, classification. 5. Mechanisms of edema development: pathogenic factors and pathogenesis of different types of edema. 6. Significance of edema for organism. 7. Etiological and pathogenetic principles of edema and dehydration treatment. 8. Disturbance of trace elements metabolism. 9. Disturbance of macronutrients metabolism. II. QUATIONS FOR SELFCONTROL. 1. Types of water balance disturbances. 2. Extracellular water sector. 3. Basic mechanisms of volume water sectors changes. 4. Types of dehydration according to mechanisms of development. 5. Mechanisms of dehydration caused by primary absolute lack of water. 6. Types of dehydration according to speed of water losing. 7. Types of dehydration according to degree of water or electrolyte lack. 8. Pathological conditions when develops " water deficiency due to of limited water supply." 9. Manifestations of intracellular dehydration. 10. Main mechanisms of dehydration from due to a lack of electrolytes. 11. Main causes of hyperosmolar dehydration in the loss of electrolytes through the gastrointestinal tract. 12. Phenomena arising from the violation of the blood supply to the nervous tissue during dehydration. 13. Definition of edema. 14. Classification of edema according to prevalence. 15. Classification of edema according to speed of development. 16. Classification of edema according to pathogenesis. 17. Classification of edema according to etiology. 18. Definition of dropsy. 19. Types of dropsy. 20. Types of lymphatic insufficiency. 21. -
The Journey of Kidney Disease
2/8/2021 THE JOURNEY OF KIDNEY DISEASE • BY LORETTA DICAMILLO DNP, MSN,RN • RENAL SPECIALISTS • FEBRUARY 6, 2021 FUNCTIONS OF THE KIDNEY The most Vascular organ of the body… Maintenance of body fluids Excretion of wastes Regulation of blood pressure Production of hormones 1 2/8/2021 STATISTICS U.S Department of Health and Human Services More than 726 thousand Americans in 2016 were on dialysis or living with a kidney transplant. Each day over 240 individuals on dialysis pass away. Chronic kidney disease (CKD) is more common in people age 65 and older. 40% of hospitalizations for acute kidney injury (AKI) were among persons with diabetes. The total number of hospitalizations have increased from 900 thousand in the year 2000 to over 3 million in the year 2014. RISKS OF AKI NON-MODIFIABLE MODIFIABLE CHRONIC LIVER DISEASE ANEMIA, HYPERTENSION CONGESTIVE HEART HYPONATREMIA FAILURE, DIABETES HYPOALBUMINEMIA > 65 YEARS OF AGE DRUG USAGE, SEPSIS PERIPHERICAL VASCULAR RHABDOMYOLYSIS DISEASE RENAL ARTERIAL STENOSIS 2 2/8/2021 STAGES OF AKI KDIGO GUIDELINES STAGE 1 STAGE 2 STAGE 3 CREATININE X 1.5 CREATININE X2 CREATININE X 3 BASELINE BASELINE BASELINE OR AN INCREASE TO > 4.0 >0.3 MG/DL URINE OUTPUT < 0.5 MG/DL OLIGURIA < 0.5 MG/KG/HR. FOR > 12 MG/KG/HR. X 6-12 HRS. HRS. ANURIA FOR >12 HRS. BY STAGE THREE PROBABLY NEED RENAL REPLACEMENT THERAPY (RRT) ETIOLOGIES OF AKI PRERENAL – 25% INTRINSIC - 65% PRE-RENAL INTRINSIC POST- ATI- 45% RENAL AKI ON CKD -13% Etiology Hypoperfusion True Kidney Obstruction GN OR VASCULITIS -4% Injury ATHEROEMBOLIC - 1% POSTRENAL – 10% FENa 1% 3.4% Low Yield 3 2/8/2021 PATHOPHYSIOLOGY COMMON ENDPOINT IN ALL TYPES OF ATI IS CELLULAR INSULT SECONDARY TO ISCHEMIA OR DIRECT TOXINS, EFFACEMENT OF THE BRUSH BORDER AND EVENTUALLY CELL DEATH, WHICH SHUTS DOWN THE FUNCTION OF TUBULAR CELLS.